Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.44 |
| ▸ | GSK3B | P49841 | 5/20 | 0.40 |
| ▸ | CLK4 | Q9HAZ1 | 4/20 | 0.40 |
| ▸ | ROCK2 | O75116 | 4/20 | 0.40 |
| ▸ | CHEK2 | O96017 | 4/20 | 0.40 |
| ▸ | PRKACA | P17612 | 4/20 | 0.40 |
| ▸ | RPS6KB1 | P23443 | 4/20 | 0.40 |
| ▸ | AKT1 | P31749 | 4/20 | 0.40 |
| ▸ | RPS6KA3 | P51812 | 4/20 | 0.40 |
| ▸ | ROCK1 | Q13464 | 4/20 | 0.40 |
| ▸ | PRKG1 | Q13976 | 4/20 | 0.40 |
| ▸ | PKN2 | Q16513 | 4/20 | 0.40 |
| ▸ | CDC42BPA | Q5VT25 | 4/20 | 0.40 |
| ▸ | HIPK4 | Q8NE63 | 4/20 | 0.40 |
| ▸ | AURKB | Q96GD4 | 4/20 | 0.40 |
| ▸ | CHEK1 | O14757 | 3/20 | 0.40 |
| ▸ | AKT2 | P31751 | 3/20 | 0.40 |
| ▸ | CLK2 | P49760 | 3/20 | 0.40 |
| ▸ | PRKAA1 | Q13131 | 3/20 | 0.40 |
| ▸ | PRKG2 | Q13237 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4599292 | 0.88 | HIF1A (0.48) | MAPKAPK2GSK3BCLK4ROCK2CHEK2 | |
| SCHEMBL4596918 | 0.84 | GSK3B (0.46) | MAPKAPK2GSK3BCLK4ROCK2CHEK2 | |
| SCHEMBL4598269 | 0.83 | KDM1A (0.46) | MAPKAPK2GSK3BCLK4ROCK2CHEK2 | |
| SCHEMBL4917135 | 0.83 | CHEK2 (0.46) | MAPKAPK2GSK3BCLK4ROCK2CHEK2 | |
| SCHEMBL4925124 | 0.83 | MAPKAPK2 (0.53) | MAPKAPK2GSK3BCLK4ROCK2CHEK2 | |
| SCHEMBL4928373 | 0.83 | MAPKAPK2 (0.42) | MAPKAPK2GSK3BCLK4ROCK2CHEK2 | |
| SCHEMBL4926848 | 0.81 | MAPKAPK2 (0.57) | MAPKAPK2GSK3BCLK4ROCK2CHEK2 | |
| SCHEMBL4927599 | 0.81 | MAPKAPK2 (0.57) | MAPKAPK2GSK3BCLK4ROCK2CHEK2 | |
| SCHEMBL4925265 | 0.81 | MAPKAPK2 (0.57) | MAPKAPK2GSK3BCLK4ROCK2CHEK2 | |
| SCHEMBL4919519 | 0.79 | GSK3B (0.45) | MAPKAPK2GSK3BCLK4ROCK2CHEK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080312244-A1 | Squaric Acid Derivatives as Protein Kinase Inhibitors | MERCK PATENT GMBH (DE) | 2008-12-18 | — | — | US | claimed |
| US-20080312244-A1 | Squaric Acid Derivatives as Protein Kinase Inhibitors | MERCK PATENT GMBH (DE) | 2008-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080312244-A1 | Squaric Acid Derivatives as Protein Kinase Inhibitors | CHEK1, CHEK2, SIK1 | MAPKAPK2 377/4885GSK3B 164/4885CLK4 129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.